ICD-10-CM Code C92: Myeloid leukemia and Related Diagnosis Codes.


The ICD-10-CM (the International Classification of Diseases, Tenth Revision, Clinical Modification) is a standardized coding system used when classifying diseases and medical conditions. Healthcare providers report these codes on Medical claims when diagnosing patient care.

Explore ICD-10-CM codes, organized by chapters based on body systems and medical conditions, as outlined in the International Classification of Diseases, Tenth Revision, Clinical Modification.

Tip: Have a specific ICD-10-CM code? Use our simple to use ICD-10-CM Code Lookup tool.

Eclaims - ICD-10-CM Tabular Code List v1.0.0

A categorized list of ICD-10-CM codes organized by chapters based on body systems or medical conditions, according to the International Classification of Diseases, Tenth Revision, Clinical Modification.

Questions
Results
  • C92 - Myeloid leukemia
    • C92.0 - Acute myeloblastic leukemia
      • C92.00 - Acute myeloblastic leukemia, not having achieved remission
      • C92.01 - Acute myeloblastic leukemia, in remission
      • C92.02 - Acute myeloblastic leukemia, in relapse
    • C92.1 - Chronic myeloid leukemia, BCR/ABL-positive
      • C92.10 - Chronic myeloid leukemia, BCR/ABL-positive, not having achieved remission
      • C92.11 - Chronic myeloid leukemia, BCR/ABL-positive, in remission
      • C92.12 - Chronic myeloid leukemia, BCR/ABL-positive, in relapse
    • C92.2 - Atypical chronic myeloid leukemia, BCR/ABL-negative
      • C92.20 - Atypical chronic myeloid leukemia, BCR/ABL-negative, not having achieved remission
      • C92.21 - Atypical chronic myeloid leukemia, BCR/ABL-negative, in remission
      • C92.22 - Atypical chronic myeloid leukemia, BCR/ABL-negative, in relapse
    • C92.3 - Myeloid sarcoma
      • C92.30 - Myeloid sarcoma, not having achieved remission
      • C92.31 - Myeloid sarcoma, in remission
      • C92.32 - Myeloid sarcoma, in relapse
    • C92.4 - Acute promyelocytic leukemia
      • C92.40 - Acute promyelocytic leukemia, not having achieved remission
      • C92.41 - Acute promyelocytic leukemia, in remission
      • C92.42 - Acute promyelocytic leukemia, in relapse
    • C92.5 - Acute myelomonocytic leukemia
      • C92.50 - Acute myelomonocytic leukemia, not having achieved remission
      • C92.51 - Acute myelomonocytic leukemia, in remission
      • C92.52 - Acute myelomonocytic leukemia, in relapse
    • C92.6 - Acute myeloid leukemia with 11q23-abnormality
      • C92.60 - Acute myeloid leukemia with 11q23-abnormality not having achieved remission
      • C92.61 - Acute myeloid leukemia with 11q23-abnormality in remission
      • C92.62 - Acute myeloid leukemia with 11q23-abnormality in relapse
    • C92.A - Acute myeloid leukemia with multilineage dysplasia
      • C92.A0 - Acute myeloid leukemia with multilineage dysplasia, not having achieved remission
      • C92.A1 - Acute myeloid leukemia with multilineage dysplasia, in remission
      • C92.A2 - Acute myeloid leukemia with multilineage dysplasia, in relapse
    • C92.Z - Other myeloid leukemia
      • C92.Z0 - Other myeloid leukemia not having achieved remission
      • C92.Z1 - Other myeloid leukemia, in remission
      • C92.Z2 - Other myeloid leukemia, in relapse
    • C92.9 - Myeloid leukemia, unspecified
      • C92.90 - Myeloid leukemia, unspecified, not having achieved remission
      • C92.91 - Myeloid leukemia, unspecified in remission
      • C92.92 - Myeloid leukemia, unspecified in relapse

Note: The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes are developed and maintained by the Centers for Disease Control and Prevention (CDC). CDC's National Center for Health Statistics (NCHS) is responsible for the clinical modification of ICD-10 for use in the United States. The World Health Organization (WHO), which owns and publishes ICD-10, authorized NCHS to develop ICD-10-CM. All modifications to ICD-10 must conform to WHO's established ICD structure and conventions. All rights are reserved by the respective entities.